Skip to Primary Navigation

Skip to main content

Michelle Mantine: DOJ’s targeted review strategy and healthcare companies

The DOJ’s Antitrust Division is returning to targeted Second Request investigations.

Article label: Interview
Premium article

Kevin Kinsella

Montage with Michelle Mantine and Department of Justice building in the background.
GRIP Montage: Reed Smith/Eric Lee/Getty Images
Click to share on Facebook (Opens in new window/tab) Click to share on X (Opens in new window/tab) Click to share on LinkedIn (Opens in new window/tab) Click to share on WhatsApp (Opens in new window/tab)
competitive concerns. Associate
, , , , , ,

Get full access, free for a month

This is a Premium article. Start your 28-day free trial to continue reading and access all content on GRIP – no payment details required.

Start free trial
Sign in

What’s included:

  • Every new article, plus our 6,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience